Aug. 31, 2020 – Following the Democratic and Republican convention attacks on big pharma and President Trump’s acceptance speech for his party’s nomination for re-election – in which he claimed to have already taken effective action to lower prescription drug prices through Executive Orders – the Pharmaceutical Research and Manufacturers of America (PhRMA) is making […]
Read more
July 29, 2019 — Last week’s agreement on parameters for the 2020 fiscal year federal budget is good news for the Food and Drug Administration (FDA). The greatest advantage of the deal for the White House, the Democratic leadership of the House, and the Republican leadership in the Senate, of course, is that it would […]
Read more
May 4, 2018 – A drug pricing initiative expected from the White House May 8 is likely to include a number of incremental steps on drug pricing to support a strategy that is trickling down from President Trump to Health & Human Services Secretary Alex Azar and FDA Commissioner Scott Gottlieb, M.D. This initiative may […]
Read more